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Abstract
Objective: This study investigated the relationship between aortic 18F-fluoro-2-deoxy-D-glucose (18F-FDG) uptake and
clinical and laboratory findings related to atherosclerosis in a general population.
Methods: 18F-FDG uptake in the ascending aorta was measured on the positron emission tomography/computed
tomography (PET/CT) scans of 211 Japanese adults. The maximum target-to-background ratio (TBR) was compared with
clinical and laboratory atherosclerosis findings.
Results: By multivariate regression analysis adjusted for age and sex, TBR-ascending aorta (TBR-A) was significantly
correlated with various clinical and laboratory parameters, such as body mass index, log visceral fat area, low-density
lipoprotein cholesterol (LDL-C), log fasting immunoreactive insulin, log homeostasis model assessment of insulin resistance,
log total adiponectin and log-leptin, in all subjects. Furthermore, by multivariate linear regression analysis adjusted for
confounding factors, TBR-A was significantly correlated with LDL-C (b = 0.001, p = 0.03) and log-leptin (b = 0.336, p,0.01) in
all subjects.
Conclusion: TBR-A was significantly correlated with LDL-C and log-leptin independent from confounding factors. Our results
suggest that aortic 18F-FDG uptake is a good marker of atherosclerosis, even in a general population.
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Introduction
Atherosclerotic diseases such as coronary heart disease and
cerebrovascular disease are the leading cause of illness and death
worldwide [1]. Although controlling risk factors such as smoking,
blood pressure, and serum lipid levels [2] to reduce atherothrom-
botic events is recommended, a fifth of all cardiovascular events
occur in individuals with no identifiable traditional risk factors [3].
Recently, atherosclerosis has been recognized as an inflammatory
disease [4]. It is well known that plaque composition and biologic
activity contribute significantly to the risk of vascular events [5,6];
however, since angiography is invasive for the evaluation of
atherosclerosis, plaque inflammation and vulnerability cannot be
directly observed [7].
Collectively, adipose tissue can be perceived a large gland that
produces adipocytokines. Some studies have suggested that
inflammation and dysfunction of adipose tissue in obesity may
induce abnormal production of adipocytokines and result in the
higher incidence of cardiovascular diseases among obese people
[8]. Adipocytokines such as leptin and adiponectin play important
roles in the metabolic regulation of obesity and obesity-related
complications.
Leptin is mainly produced by white adipose tissue [9] and its
production is regulated by energy level, food intake, several
hormones, and various inflammatory mediators [10]. Leptin also
provides the functional link between the immune system and
energy homeostasis [11]. Hyperleptinemia in the general popula-
tion is associated with atherosclerosis, hypertension, and metabolic
syndrome [10]. Increased serum concentrations of leptin are also
associated with an increased risk of myocardial infarction and
stroke, independent of obesity and other traditional cardiovascular
risk factors [12].
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18F-fluoro-2-deoxy-D-glucose positron emission tomography
(18F-FDG-PET) is an imaging modality to detect glucose
metabolism in normal and disease states such as malignancies
[13]. Recent technological advances have enabled the non-
invasive use of FDG-PET imaging within a short period [14,15].
Although FDG-PET has been mainly used for cancer diagnosis
and early detection, it can also detect inflammatory changes in the
arterial wall, which may represent early stages of atherosclerosis
[16,17]. Previous studies showed FDG accumulation in athero-
sclerotic plaques [18–20]. However, availability of 18F-FDG
uptake for the evaluation of the development of atherosclerosis
remains unclear.
In this study, we thus evaluated a general population to
investigate the relationship between aortic 18F-FDG uptake and
clinical parameters in the development of atherosclerotic disease.
Methods
1.1. Study subjects
The study was conducted during a cancer-screening program at
the Nishi-Isahaya Hospital PET/CT Diagnostic Imaging Center
(Nagasaki, Japan). We initially included 253 consecutive study
candidates who underwent PET/CT screening for malignancies at
the Center between June 2012 and April 2013. Among these
subjects, we excluded 42 subjects for following reasons: 2 had
glycosylated hemoglobin A1c (HbA1c) at .7.0%; 3 had dyslipide-
mia and low-density lipoprotein cholesterol (LDL-C).
6.48 mmol/L and/or high-density lipoprotein cholesterol (HDL-
C),0.78 mmol/L and/or triglyceride (TG) .3.39 mmol/L; 9
had cerebral infarction or hemorrhage[21]; 13 had apparent
chronic kidney disease; 13 had collagen disease, including
rheumatoid arthritis; and 2 had current malignant tumors.
Ultimately, 211 Japanese participants (119 men and 92 women)
were included in the study. None of the participants showed
malignancies on PET/CT. The study was approved by the ethics
committee of Nagasaki University (project registration number
12053002), and written informed consent was obtained from all
participants.
1.2. Data collection and laboratory measurements
A questionnaire was administered to evaluate medical history,
smoking habits, and drug use. Height and weight were measured,
and body mass index (BMI; kg/m2) was calculated. Blood pressure
(BP) was measured in a supine position using a standard
sphygmomanometer.
Blood samples were collected from each participant after
overnight fasting for the measurements of lipid profile, fasting
plasma glucose (FPG), fasting immunoreactive insulin (IRI),
HbA1c as defined by the National Glycohemoglobin Standardi-
zation Program (NGSP), 1,5-anhydroglucitol (1,5-AG), creatinine
(Cr), uric acid (UA), high sensitive C-reactive protein (hs-CRP),
high-molecular-weight adiponectin (HMW-A), total adiponectin
(T-A), and leptin. Insulin resistance was estimated using the
homeostasis model assessment of insulin resistance (HOMA-IR)
from FPG and IRI concentrations using the following formula:
HOMA-IR = (fasting IRI [mU/ml] 6 FPG [mg/dl])/405.
Estimated glomerular filtration rate (eGFR) was calculated using
creatinine, age, and sex [22].
Serum T-A, HMW-A, leptin concentrations were measured
using commercial kits, and visceral fat area was measured by body
fat meter.
1.3. 18F-FDG-PET/CT imaging
The PET/CT imaging study was performed with a PET/CT
scanner (Discovery ST; GE Healthcare, Milwaukee, Wisconsin,
USA). Details of this procedure have been described elsewhere
[23–25]. In brief, imaging was started 50 min after intravenous
injection of 18F-FDG through an anterior cubital vein. Injected
18F-FDG doses were determined according to each subject’s
weight (4 MBq/kg); individual doses ranged from 146.2–
403.8 MBq. The patients fasted for at least 6 h before 18F-FDG
injection, and the glucose level of each participant was measured
using a simple method before 18F-FDG injection. All participants
showed glucose levels lower than 11.10 mmol/L (3.66–8.94). Each
participant was scanned in the supine position with his or her arms
placed alongside the body. The image acquisition time was
2.5 min per bed position. There were 7–8 bed positions, which
allowed scanning of the entire body in a three-dimensional mode.
The acquisition parameters for dual-detector helical CT were
140 kV, 30 mA, 3.75-mm slice thickness, and a pitch of 1.5.
Attenuation correction was performed with acquired CT data.
The PET/CT images displayed as coronal, sagittal, and transaxial
slices were viewed on dedicated Workstation (Xeleris, GE
Healthcare) [23].
1.4. Image Analysis
The PET and CT images of each participant were analyzed
using a dedicated image analyzing software on a personal
computer. The PET and CT images were superimposed to form
a fused PET/CT image using the program. For the index of
glucose metabolic activity in the common carotid arteries and
ascending aorta, we calculated standardized uptake values (SUVs)
of 18F-FDG in each region of interest (ROI). The ROIs of the
common carotid arteries were obtained from 10 consecutive
tomographic slices, beginning from the merging point with the
carotid bifurcation [20]. The ROIs of the ascending aorta were
also obtained from 10 consecutive tomographic slices, beginning
from the merging point with the aortic arch. Maximum SUVs
were obtained from each ROI. Blood-pool activity was measured
by placing a circular ROI in the mid lumen of the superior vena
cava on two different tomographic slices and then averaging the
values to obtain the background SUV. The maximum SUVs of
each arterial segment were averaged for both carotid arteries and
the ascending aorta, and were then divided by the background
SUV to yield maximum target-to-background ratios (TBR) for
each patient [26] (Figure 1).
Prior to the analysis, we evaluated the correlation between
TBR-ascending aorta (TBR-A) and other TBRs, such as TBR-
right common carotid artery, TBR-left common carotid artery,
TBR-right carotid bifurcation, and TBR-left carotid bifurcation,
in 60 randomly selected subjects. We confirmed high correlations
(r = 0.64, p,0.01 vs. TBR-right common carotid artery, r = 0.65,
p,0.01 vs. TBR-left common carotid artery, r = 0.60, p,0.01 vs.
TBR-right carotid bifurcation and r = 0.59, p,0.01 vs. TBR-left
carotid bifurcation). Based on these results, TBR-A was used for
analysis in this study.
1.5. Statistical Analysis
Results are expressed as mean 6 standard deviation (SD).
Differences in continuous values between men and women were
compared using the Mann-Whitney U test, and differences
between categorized values were evaluated using the x2-test. As
visceral fat area, TG, IRI, HOMA-IR, 1,5-AG, HMW-A, T-A,
leptin, and hs-CRP showed a skewed distribution, logarithmic
transformation was performed for multivariate linear regression
analysis. Simple correlations of TBR-A with other variables were
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evaluated using univariate linear regression analysis. The corre-
lations of TBR-A adjusted for age, sex, and other confounding
factors (log visceral fat area, LDL-C, log HOMA-IR, and log
leptin) were evaluated by multivariate linear regression analysis. A
P-value ,0.05 was considered statistically significant. All statistical
analyses were performed using statistical software.
Results
The characteristics of the study subjects are shown in Table 1.
Subjects had a mean age (6SD) of 54.468.9 years (range, 34–75
years) in 119 men. For the 92 women, the mean age was
56.5610.9 years (range, 33–87 years) (p = 0.38). TBR-A of men
(1.7460.39) was significantly higher than that of women
(1.5460.20) (p,0.01).
Table 2 shows the correlation coefficients of TBR-A with other
variables as determined by univariate regression analysis. TBR-A
was significantly correlated with BMI, waist circumference,
visceral fat area, diastolic BP, FPG, TG, UA, Cr, IRI, HOMA-
IR, HMW-A, T-A, and hs-CRP in all subjects. TBR-A was
significantly correlated with BMI, IRI, HOMA-IR, and leptin in
both men and women. Furthermore, TBR-A was significantly
correlated with UA in men and waist circumference in women.
By multivariate regression analysis adjusted for age and sex,
TBR-A was significantly correlated with BMI, waist circumfer-
ence, log visceral fat area, diastolic BP, LDL-C, log TG, UA, Cr,
log IRI, log HOMA-IR, log T-A, log-leptin, and log hs-CRP in all
subjects (Table 3).
Furthermore, by multivariate linear regression analysis adjusted
for confounding factors, TBR-A was significantly correlated with
LDL-C (b = 0.001, p = 0.03) and log leptin (b = 0.336, p,0.01), as
were age and sex, in all subjects (Table 4).
Discussion
By multivariate regression analysis adjusted for age and sex, we
showed that TBR-A was significantly correlated with various
clinical and laboratory parameters, such as BMI, log visceral fat
area, LDL-C, log TG, log IRI, log HOMA-IR, log T-A and log-
leptin. Furthermore, by multivariate linear regression analysis
adjusted for confounding factors, we showed that LDL-C and log-
leptin were significantly correlated with TBR-A.
Recent studies reported that 18F-FDG PET could be a useful
tool for the measurement of vascular inflammation. Histological
studies by Rudd et al. indicated that FDG accumulation was
localized within the atherosclerotic plaques [18]. Tawakol et al.
showed that FDG-PET imaging can determine the in vivo
macrophage content of carotid plaques [19], while Tahara et al.
showed strong FDG accumulation in the carotid artery in an
atherosclerotic plaque lesion [20]. Further studies confirmed that
FDG uptake by the carotid artery wall was associated with
atherosclerotic markers in healthy individuals [26–28]. In this
study, we showed that TBR-A was significantly associated with
BMI, which is consistent with previous studies [20,27].
Univariate regression analysis revealed a significant relationship
between TBR-A and leptin in both men and women, but not in all
subjects. A greater serum leptin level has been reported in women
than in men [29], which is consistent with our current study
findings. These different profiles of leptin levels for men and
women resulted in the non-significant correlation observed by
univariate regression analysis between TBR-A and leptin in all
subjects in the present study.
On the other hand, we first reported that TBR-A was
significantly associated with leptin after adjusting for confounding
factors. Hyperleptinemia in the general population is associated
with atherosclerotic disease and their risk factors [10,12]. This
may be partly explained by the fact that increased leptin leads to
increased insulin resistance, homeostasis imbalance, and vascular
inflammation [30]. Dubey et al. reported that leptin and hs-CRP
were independent predictors for complex lesion morphology in
unstable angina [31]. Leptin is reported to play an important role
in the early stages of atherosclerosis development by initiating
leukocyte and macrophage recruitment to the endothelial wall
[10]. Schneiderman et al. also showed that neurologically
symptomatic patients overexpress leptin mRNA and synthesize
leptin protein in carotid plaque macrophages and smooth muscle
cells. This induction might be activated by cytokines like TNF-a
when these are available within the plaque and in the systemic
circulation. Excessive synthesis of leptin within the plaque could
have paracrine or autocrine effects that could lead to destabiliza-
tion of the atherosclerotic lesion, resulting in embolic complica-
tions [32]. In combination with our results, these suggest that
leptin is a biomarker of active plaque. We also found that TBR-A
Figure 1. Diagrammatic representation of how to place the ROIs on PET/CT image of a 63-year-old man. (a) Coronal section with ROI.
(b) Axial section with ROI of superior vena cava and ascending aorta. (c) Axial section with ROI of right carotid artery.
doi:10.1371/journal.pone.0111990.g001
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is significantly correlated with LDL-C after adjusting for
confounding factors. It is well known that high serum levels of
LDL-C play a main role in the initiation and progression of
atherosclerosis [33]. The nascent plaque progresses over time to
form a raised lesion consisting of a fibrous layer of scar tissue
overlying a lipid-rich core. These raised fibrous plaques then
progress at a rate that is proportional to the circulating level of
plasma LDL-C to ultimately form larger and more complex
lesions, which continue to progress and can eventually become
vulnerable to disruption [34,35]. Tahara et al. showed that LDL-
C-lowering therapy with statin attenuates plaque inflammation
evaluated by FDG-PET [36]. Further studies are needed to clarify
the relationship between aortic 18F-FDG uptake and lipid
metabolism.
Montecchi et al. reported that type 2 diabetes caused
atherosclerosis at a more accelerated rate than hypercholesterol-
emia [37]. However, we could not find a significant relationship
between TBR-A and markers related with glycometabolism such
as HbA1c and HOMA-IR. This is probably because only 3.3% of
the patients in this present study were diabetic, and the subjects
whose HbA1c was .7% or whose glucose levels were higher than
11.10 mmol/L were excluded. It may be difficult to assess the
influence of hyperglycemia to vascular inflammation by FDG-
PET, since the FDG uptake rate in tissues is enhanced by high
plasma glucose levels [38,39].
One interesting finding was that multivariate linear regression
analysis of 152 of 211 subjects with no treatment for atheroscle-
rotic risk factors revealed a significant correlation between TBR-A
and log leptin (b = 0.623, p,0.01), but not with LDL-C (b = 0,
Table 1. Characteristics of the Study Population.
Men (n = 119) Women (n = 92) All (n = 211) p
Age (years) 54.468.9 56.5610.9 55.369.9 0.38
BMIa (kg/m2) 24.163.0 22.263.0 23.363.2 ,0.01**
Waist circumference (cm) 85.569.7 82.068.9 84.069.5 0.02*
Visceral fat area (cm2) 116.4636.4 79.6629.4 100.4638.1 ,0.01**
Systolic BPb (mmHg) 124.2612.7 117.3612.6 121.2613.1 ,0.01**
Diastolic BPb (mmHg) 79.669.0 72.0610.0 76.3610.2 ,0.01**
FPGc (mmol/L) 5.4860.71 5.0460.40 5.2860.63 ,0.01**
HbA1c
d (NGSP) (%) 5.560.4 5.460.3 5.560.4 0.58
LDL-C (mmol/L) 3.0560.78 3.4560.93 3.2260.87 ,0.01**
HDL-C (mmol/L) 1.4760.34 1.6860.34 1.5660.36 ,0.01**
TG (mmol/L) 1.2960.74 0.9760.41 1.1560.64 ,0.01**
UAe (mmol/L) 362.86671.38 261.73659.49 315.27683.28 ,0.01**
Crf (mmol/L) 70.72610.61 53.0468.84 62.76613.26 ,0.01**
eGFRg (mL/min/1.73 m2) 81.3614.0 81.5614.5 81.4614.2 0.63
TBR-Aortah 1.7460.39 1.5460.20 1.6560.33 ,0.01**
IRIi (pmol/L) 32.64626.25 25.90614.45 29.72622.09 0.20
HOMA-IRj 1.1860.99 0.8560.51 1.0360.83 0.04*
1,5-AGk (mmol/L) 138.28661.53 115.14646.91 127.93656.65 ,0.01**
HMW-Al (mg/L) 3.4762.12 5.9163.18 4.5362.89 ,0.01**
T-Am (mg/L) 8.463.5 13.365.9 10.665.3 ,0.01**
Leptin (mg/L) 2.9761.83 5.6863.05 4.1562.78 ,0.01**
hs-CRPn (nmol/L) 8.92616.42 11.29648.56 9.95634.27 ,0.01**
Anti-hypertensive agents 20.2% 19.8% 20.0% 0.94
Anti-diabetic agents 4.2% 2.2% 3.3% 0.42
Statin 10.1% 6.6% 8.6% 0.37
Lipid-lowering agents 14.3% 7.7% 11.4% 0.14
Antiplatelet agents 8.4% 3.3% 6.2% 0.13
Gout remedy 8.4% 0% 4.8% ,0.01**
Smoking history ,0.01**
none 24.6% 85.9% 51.4%
current smoke 30.5% 5.4% 19.5%
past smoke 44.9% 8.7% 29.0%
**; p,0.01, *; p,0.05.
a body mass index, b blood pressure, c fasting plasma glucose, d glycosylated hemoglobin A1c,
e uric acid, f creatinine, g estimated glomerular filtration rate, h target-to-
background ratio-ascending aorta, iimmunoreactive insulin, j homeostasis model assessment of insulin resistance, k 1,5-anhydroglucitol, l high-molecular-weight
adiponectin, m total adiponectin, n high sensitive C-reactive protein.
doi:10.1371/journal.pone.0111990.t001
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Table 2. Correlation Coefficients of the TBR-Aorta with Other Variables as Determined by Univariate Regression Analysis.
Men (n = 119) Women (n = 92) All (n = 211)
Age 20.047 0.065 20.019
BMI 0.264** 0.244* 0.318**
Waist Circumference 0.179 0.207* 0.224**
Visceral Fat Area 0.125 0.204 0.235**
Systolic BP 20.008 20.019 0.065
Diastolic BP 0.098 0.056 0.196**
FPG 0.011 0.094 0.144*
HbA1c 0.070 20.012 0.041
LDL-C 0.168 0.151 0.090
HDL-C 0.019 20.007 20.079
TG 0.145 0.044 0.165*
UA 0.218* 0.063 0.300**
Cr 0.111 0.189 0.276**
eGFR 20.079 20.181 20.120
IRI 0.202* 0.209* 0.205**
HOMA-IR 0.183* 0.214* 0.206**
1,5-AG 20.092 0.136 0.057
HMW-A 20.129 20.179 20.265**
T-A 20.126 20.181 20.264**
Leptin 0.244** 0.369** 0.078
hs-CRP 0.149 0.106 0.176*
**; p,0.01, *; p,0.05.
doi:10.1371/journal.pone.0111990.t002
Table 3. Multiple Linear Regression Analysis of TBR-Aorta Adjusted for Age and Sex in All Subjects.
b 95%CI p
BMI 0.036 0.022, 0.049 ,0.01**
Waist Circumference 0.008 0.003, 0.013 ,0.01**
log Visceral Fat Area 0.440 0.140, 0.740 ,0.01**
Systolic BP 0.001 20.003, 0.005 0.52
Diastolic BP 0.005 0.000, 0.009 ,0.05*
FPG 0.002 20.002, 0.006 0.34
HbA1c 0.052 20.065, 0.169 0.38
LDL-C 0.002 0.001, 0.003 ,0.01**
HDL-C 0.000 20.004, 0.003 0.78
log TG 0.300 0.088, 0.513 ,0.01**
UA 0.047 0.009, 0.085 0.02*
Cr 0.431 0.030, 0.832 0.04*
eGFR 20.003 20.007, 0.000 0.06
log IRI 0.099 0.003, 0.195 0.04*
log HOMA-IR 0.100 0.006, 0.194 0.04*
log 1,5-AG 0.010 20.076, 0.095 0.82
log HMW-A 20.130 20.302, 0.042 0.14
log T-A 20.242 20.482, 20.002 ,0.05*
log leptin 0.357 0.196, 0.518 ,0.01**
log hs-CRP 0.107 0.021, 0.194 0.02*
**; p,0.01, *; p,0.05.
b: standardized regression coefficient.
95%CI: 95% confidence interval.
doi:10.1371/journal.pone.0111990.t003
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p = 0.80). This may suggest that a general population with no
treatment for atherosclerotic risk factors is less likely to have
progressive atherosclerotic disease.
There are some limitations to this study. There may have been a
selection bias, as individuals who participated in cancer screening
by PET/CT were enrolled in the study. The sample size was
relatively small, and other non-invasive methods for atherosclero-
sis, such as carotid intima-media thickness or ankle-brachial index,
could not be evaluated. We were also unable to assess calcium
score because we obtained these images without cardiac gating
and without the patients holding their breath. Further studies are
needed to clarify the availability of aortic 18F-FDG uptake to
clinical and laboratory findings related with atherosclerosis.
In conclusion, TBR-A was significantly correlated with LDL-C
and log-leptin, independent from confounding factors. Our results
suggest that aortic 18F-FDG uptake is a good marker of
atherosclerosis, even in a general population.
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